Clinical Trial Update: A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 study evaluating CKD-506 for efficacy and safety in adults with moderate-to-severe rheumatoid arthritis who did not respond to methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CKD-506

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED